PA

Priti Arun Joshi

Director Additional Director DIN 01424256
DIN 01424256 First appointment Jul 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2005
Shareholding value •••• Premium profile

About Priti Arun Joshi

Data last updated:

Priti Arun Joshi was an Additional Director at Mc Coy Drugs Private Limited (2007–2009) and Director at Surya Life Sciences Limited (2005–2012). The companies operate in Pharma and Chemicals and Materials.

DIN 01424256
Primary Designation Additional Director
Industry Pharma
First Appointment 04 Jul 2005

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mc Coy Drugs Private Limited U24230GJ2004PTC098840
Additional Director07 Jul 20072004₹11.59 Cr (FY 2025)Active
Surya Life Sciences Limited U24230MH2005PLC154467
Director04 Jul 20052005₹119 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mc Coy Drugs Private Limited
Surya Life Sciences Limited
Premium access

Shareholding and investment profile for Priti Arun Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priti Arun Joshi

Priti Arun Joshi was first appointed on 04 Jul 2005 as Director at Surya Life Sciences Limited. The most recent appointment on record is 07 Jul 2007 at Mc Coy Drugs Private Limited.

Priti Arun Joshi held 2 earlier board appointments: Mc Coy Drugs Private Limited (Additional Director, 07 Jul 2007 to 15 May 2009); Surya Life Sciences Limited (Director, 04 Jul 2005 to 18 Oct 2012).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available